Screening |
Who needs it |
How often |
Alcohol misuse |
All adults |
At routine exams |
Blood pressure |
All adults |
Yearly checkup if your blood pressure is normal* Normal blood pressure is less than 120/80 mm Hg* If your blood pressure reading is higher than normal, follow the advice of your healthcare provider |
Depression |
All men in this age group |
At routine exams |
Type 2 diabetes or prediabetes |
All men beginning at age 45 and men without symptoms at any age who are overweight or obese and have 1 or more additional risk factors for diabetes |
At least every 3 years (annually if blood sugar is already rising) |
Type 2 diabetes |
All men with prediabetes |
Every year |
Hepatitis C |
Anyone at increased risk |
At routine exams |
HIV |
All men |
At routine exams |
High cholesterol and triglycerides |
All men ages 35 and older, and younger men at high risk for coronary artery disease |
At least every 5 years |
Obesity |
All adults |
At routine exams |
Prostate cancer |
Starting at age 45, talk to healthcare provider about risks and benefits of digital rectal exam (DRE) and prostate-specific antigen (PSA) screening*** |
At routine exams |
Colorectal cancer |
Men of average risk ages 45 and older |
Several tests are available and used at different times. Possible tests include:
Colonoscopy every 10 years, or
Flexible sigmoidoscopy every 5 years (or every 10 years with yearly FIT stool test), or
CT colonography (virtual colonoscopy) every 5 years, or
Colonoscopy every 10 years, or
Yearly fecal occult blood test, or
Yearly fecal immunochemical test (FIT), or
Stool DNA test, every 1 to 3 years
You will need a follow-up colonoscopy if you choose any test other than a colonoscopy and you have an abnormal result. Talk with your doctor about which tests are best for you. Some people should be screened using a different schedule because of their personal or family health history. Talk with your provider about your health history. |
Syphilis |
Anyone at increased risk for infection |
At routine exams |
Tuberculosis |
Anyone at increased risk for infection |
Check with your healthcare provider |
Vision |
All adults1 |
Every 2 to 4 years if no risk factors for eye disease |
Counseling |
Who needs it |
How often |
Diet and exercise, |
Adults who are overweight or obese |
When diagnosed and at routine exams |
Aspirin for primary prevention of cardiovascular problems |
Men ages 45 to 79, when potential benefits from a decrease in heart attacks outweigh the harm or risks from an increase in gastrointestinal hemorrhage |
When diagnosed with risk for cardiovascular/heart disease; check with your healthcare provider before starting |
Sexually transmitted infection prevention |
Anyone at increased risk for infection |
At routine exams |
Tobacco use and tobacco-related disease |
All adults |
Every exam |
Immunization |
Who needs it |
How often |
Tetanus/diphtheria/ pertussis (Td/Tdap) booster |
All adults |
Td: every 10 years Tdap: substitute a 1-time dose of Tdap for a Td booster after age 18, then boost with Td every 10 years |
Measles, mumps, rubella (MMR) |
All adults in this age group who have no record of previous infection or vaccines** |
1 or 2 doses |
Chickenpox (varicella) |
All adults in this age group who have no record of previous infection or vaccines** |
2 doses; the second dose should be given at least 4 weeks after the first dose |
Flu (seasonal) |
All adults |
Yearly, when the vaccine becomes available in the community |
Hepatitis A |
People at risk2 |
2 doses given at least 6 months apart |
Hepatitis B |
People at risk3 |
3 doses; the second dose should be given 1 month after the first dose, and the third dose should be given at least 2 months after the second dose (or at least 4 months after the first dose) |
Haemophilus influenza Type B (HIB) |
People at risk |
1 to 3 doses |
Meningococcal |
People at risk** |
1 or more doses |
Pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23) |
People at risk4 |
PCV13: 1 dose ages 19 to 65 (protects against 13 types of pneumococcal bacteria) PPSV23: 1 to 2 doses through age 64, or 1 dose at 65 or older (protects against 23 types of pneumococcal bacteria) |